116 related articles for article (PubMed ID: 16965602)
1. Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features.
Lee YM; Lee JY; Kim MJ; Bae HI; Park JY; Kim SG; Kim DS
Cancer Sci; 2006 Nov; 97(11):1205-10. PubMed ID: 16965602
[TBL] [Abstract][Full Text] [Related]
2. PGP9.5 methylation as a marker for metastatic colorectal cancer.
Mizukami H; Shirahata A; Goto T; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2008; 28(5A):2697-700. PubMed ID: 19035297
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery.
Mitsui Y; Shiina H; Hiraki M; Arichi N; Hiraoka T; Sumura M; Honda S; Yasumoto H; Igawa M
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):487-96. PubMed ID: 22246902
[TBL] [Abstract][Full Text] [Related]
4. Methylation status in the promoter region of the human PGP9.5 gene in cancer and normal tissues.
Bittencourt Rosas SL; Caballero OL; Dong SM; da Costa Carvalho Mda G; Sidransky D; Jen J
Cancer Lett; 2001 Sep; 170(1):73-9. PubMed ID: 11448537
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the Ras association domain family 1A (RASSF1A) gene in gallbladder cancer.
Kee SK; Lee JY; Kim MJ; Lee SM; Jung YW; Kim YJ; Park JY; Bae HI; Hong HS; Yun YK; Kim SG; Kim DS
Mol Cells; 2007 Dec; 24(3):364-71. PubMed ID: 18182852
[TBL] [Abstract][Full Text] [Related]
6. PGP9.5 was less frequently methylated in advanced gastric carcinoma.
Mizukami H; Goto T; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Hepatogastroenterology; 2009; 56(94-95):1576-9. PubMed ID: 19950834
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions.
García P; Manterola C; Araya JC; Villaseca M; Guzmán P; Sanhueza A; Thomas M; Alvarez H; Roa JC
Mol Carcinog; 2009 Jan; 48(1):79-89. PubMed ID: 18543280
[TBL] [Abstract][Full Text] [Related]
8. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
Shiba-Ishii A; Noguchi M
Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
[TBL] [Abstract][Full Text] [Related]
9. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.
Mandelker DL; Yamashita K; Tokumaru Y; Mimori K; Howard DL; Tanaka Y; Carvalho AL; Jiang WW; Park HL; Kim MS; Osada M; Mori M; Sidransky D
Cancer Res; 2005 Jun; 65(11):4963-8. PubMed ID: 15930319
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH
Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390
[TBL] [Abstract][Full Text] [Related]
13. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
[TBL] [Abstract][Full Text] [Related]
14. PGP9.5 as a candidate tumor marker for non-small-cell lung cancer.
Hibi K; Westra WH; Borges M; Goodman S; Sidransky D; Jen J
Am J Pathol; 1999 Sep; 155(3):711-5. PubMed ID: 10487828
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
Zhang Z; Sun D; Van do N; Tang A; Hu L; Huang G
Int J Cancer; 2007 Jan; 120(1):32-8. PubMed ID: 17013896
[TBL] [Abstract][Full Text] [Related]
17. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
18. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
19. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
[TBL] [Abstract][Full Text] [Related]
20. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
